Home » Topics » Disease categories and therapies » Infection

Infection
RSS

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Jan. 28, 1997

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Antifungal echinocandin derivatives reported by Lilly

Jan. 24, 1997

MAb from Hayashibara with IFN-inducing properties

Jan. 23, 1997

Drug screening technology available for licensing

Jan. 22, 1997

n-Docosanol efficacy demonstrated in herpes labialis

Jan. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...